Holen Sie sich die Stockscreener-App
2.25
24.26%
-0.80
Schlusskurs vom Vortag:
$3.05
Offen:
$3.05
24-Stunden-Volumen:
686.94K
Relative Volume:
3.81
Marktkapitalisierung:
$83.95M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.82M
KGV:
-7.50
EPS:
-0.3
Netto-Cashflow:
$-18.01M
1W Leistung:
-6.48%
1M Leistung:
+76.34%
6M Leistung:
+99.14%
1J Leistung:
+195.21%
1-Tages-Spanne:
$2.20
$3.15
1-Wochen-Bereich:
$2.30
$3.15
52-Wochen-Spanne:
$0.6951
$3.15
Estrella Immunopharma Inc Stock (ESLA) Company Profile
Firmenname
Estrella Immunopharma Inc
Sektor
Branche
Telefon
(510) 318-9098
Adresse
5858 HORTON STREET, SUITE 370, EMERYVILLE
Vergleichen Sie ESLA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ESLA
Estrella Immunopharma Inc
|
2.265 | 113.05M | 0 | -8.82M | -18.01M | -0.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.25 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
635.15 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
428.04 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
842.63 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.81 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Estrella Immunopharma Inc Aktie (ESLA) Neueste Nachrichten
Estrella Immunopharma's (ESLA) "Buy" Rating Reaffirmed at D. Boral Capital - MarketBeat
Check out these key findings about Estrella Immunopharma Inc (ESLA) - setenews.com
What data driven models say about Estrella Immunopharma Inc.’s future2025 Geopolitical Influence & Fast Entry Momentum Trade Alerts - newser.com
Estrella Immunopharma (NASDAQ:ESLA) Given “Buy” Rating at D. Boral Capital - Defense World
Estrella Immunopharma stock soars after 100% complete response rate in trial - Investing.com Australia
Analyst Jason Kolbert Maintains Buy Rating on ESLA | ESLA Stock News - GuruFocus
Estrella Immunopharma Completes Second Dose Cohort in STARLIGHT-1 Trial of EB103 with Complete Responses in All Evaluable Patients - The Joplin Globe
Is Estrella Immunopharma Inc. building a consolidation base2025 Market Outlook & AI Forecasted Entry/Exit Points - newser.com
Is Estrella Immunopharma Inc. stock ready for breakoutWeekly Trade Review & Long-Term Capital Growth Ideas - newser.com
Is now a turning point for Estrella Immunopharma Inc.Quarterly Portfolio Summary & Growth-Oriented Investment Plans - newser.com
Is Estrella Immunopharma Inc. reversing from oversold territoryQuarterly Profit Summary & Expert Verified Movement Alerts - newser.com
How to integrate Estrella Immunopharma Inc. into portfolio analysis tools2025 Year in Review & Fast Exit and Entry Strategy Plans - newser.com
Will Estrella Immunopharma Inc. stock gain from government policiesSell Signal & Weekly Return Optimization Plans - newser.com
What indicators show strength in Estrella Immunopharma Inc.2025 Valuation Update & Daily Chart Pattern Signals - newser.com
Leading vs lagging indicators on Estrella Immunopharma Inc. performanceLayoff News & Safe Entry Point Alerts - newser.com
Using data models to predict Estrella Immunopharma Inc. stock movementPortfolio Profit Report & Verified Swing Trading Watchlists - newser.com
Estrella Immunopharma (NASDAQ:ESLA) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat
Estrella Immunopharma, Inc. (ESLA) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
What analysts say about Estrella Immunopharma Inc stockReal Estate Investment Trusts & Low Risk Trading Portfolio - earlytimes.in
Will Estrella Immunopharma Inc. stock benefit from commodity prices2025 Earnings Impact & Free Community Consensus Stock Picks - fcp.pa.gov.br
Published on: 2025-10-28 05:18:37 - newser.com
Published on: 2025-10-27 06:57:23 - newser.com
Finanzdaten der Estrella Immunopharma Inc-Aktie (ESLA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.71%
0.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):